World Health Assembly panel to shine light on global pervasiveness of uncorrected refractive error
May 24th 2024Representatives from CooperVision and the International Agency for the Prevention of Blindness give a preview of what to expect at the "Universal Access to Glasses: Promoting Multisectoral Action" event at this year's World Health Assembly in Geneva, Switzerland.
Ocugen announces dosing completion in second cohort of GARDian clinical trial for Stargardt disease
May 20th 2024The trial evaluates OCU410ST, a modifier gene therapy candidate utilizing an AAV delivery platform for the retinal delivery of the RORA gene. The gene therapy is being designed as a one-time treatment for life.
IKA 2024: Diagnostic considerations for cataract surgery in keratoconus patients
May 19th 2024Elizabeth Yeu, MD, Executive Board Member of IKA, and a cataract and refractive surgeon at Virginia Eye Consultants, talked about cataract surgery in keratoconus, and the diagnostic considerations clinicians can take before and in the operating room.
IKA 2024: Treating keratoconus in the pediatric population
May 18th 2024Barry Eiden, OD, FAAO, FSLS, President and Co-founder of IKA, talked about his session at the meeting centering around the pediatric prevalence of keratoconus, the importance of early diagnosis, and the impact this can have on practices.
IKA 2024: Specialty contact lenses with diseased and sick eyes
May 18th 2024Christine Sindt, OD, FAAO, Clinical Professor of Ophthalmology and Visual Sciences at the University of Iowa School of Medicine, talked about her session at the meeting focusing on higher order aberrations and the correction of complicated optics on scleral contact lenses.